In the pharmaceutical world, Adverse Drug Reactions (ADRs) are not just unfortunate events — they’re regulatory red flags, patient safety threats, and potential business disasters. Why is this so critical? Because a single overlooked ADR can lead to product…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
